List view / Grid view
Scientists in the US have developed a promising new CAR T-cell therapy that targets the BAFF-R protein, which has demonstrated superior cancer destruction to existing FDA-approved CAR-T therapies.
An experiment with mice has successively blocked the immune system's T cells from killing transplanted cells.
Researchers have discovered that B cells aid T cells in fighting cancer, which could be an area of development for immunotherapies.
New study finds immunotherapy reduces cardiac fibrosis and restores heart function in mice after cardiac injury.
A new study from the University of Eastern Finland has shown that peripheral T helper cells may have a role in the development of type 1 diabetes.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
The ISCT is objecting linking the benefits of cellular immunotherapy with third party offerings of T-cell banking for future therapeutics.
New study shows that a subset of follicular helper T cells contributes to the hyposialylation of autoantibodies in rheumatoid arthritis.
CD4+ T-cells play a central role in directing adaptive immune responses against invading microbial pathogens.
Immune cell isolation and culture are necessary for both basic research aimed at investigating the functions of different immune cell types, and for expanding specific immune cell populations for therapeutic purposes.
A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.
A research team has developed a vaccine that advances anti-tumour T-cell populations and allows the cells to invade solid tumours.
New study shows the ability of CD8+ cytotoxic T cells to penetrate a large target, which opens avenues to destroy solid cancers.
Scientists have discovered a way to improve immune-based treatments by modulating T cells.
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
